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Summary 
Protein kinase Cs (PKCs) are a ubiquitous family of 
regulatory enzymes that associate with membranes 
and are activated by diacylglycerol or tumor-promot- 
ing agonists such as phorbol esters. The structure of 
the second activator-binding domain of PKC8 has been 
determined in complex with phorbo113-acetate, which 
binds in a groove between two pulled-apart 13 strands 
at the tip of the domain. The C3, C4, and C20 phorbol 
oxygens form hydrogen bonds with main-chain groups 
whose orientation is controlled by a set of highly con- 
served residues. Phorbol binding caps the groove and 
forms a contiguous hydrophobic surface covering 
one-third of the domain, explaining how the activator 
promotes insertion of PKC into membranes. 
Introduction 
Protein kinase C (PKC) denotes a family of isozymes that 
play a central role in signal transduction in eukaryotes 
(Kikkawa et al., 1989; Dekker and Parker, 1994). The iso- 
zymes differ in substrate and activator preferences and 
fulfill distinct physiological roles (Kikkawa et al., 1989). 
All of the PKC isozymes have in common a physiological 
requirement for activation by the lipophilic second mes- 
senger diacylglycerol (DAG), with the exceptions of ~ and t. 
PKC is the major cellular eceptor for the tumor-promoting 
phorbol esters, which activate PKC in a manner very simi- 
lar to DAG (Kikkawa et al., 1989; Bell and Burns, 1991; 
Newton, 1993). The use of the potent and selective phorbol 
esters as PKC activators has contributed to making the 
PKCs among the most thoroughly studied families of pro- 
tein kinases in cellular signaling. 
PKC activation is thought o proceed via the removal of 
an N-terminal autoinhibitory domain from the catalytic site 
(Orr and Newton, 1994; Kemp et al., 1994), but detailed 
structural information on the process of binding and activa- 
tion of PKCs by DAG and tumor promoters has been scant. 
Both DAG and phorbol ester binding occur at two con- 
served cysteine-rich regions of PKC (Ono et al., 1989; 
Burns and Bell, 1991; Quest et al., 1994; Kazanietz et 
al., 1994). The first and second cysteine-rich regions are 
closely related and are referred to as the cysl and cys2 
domains, respectively. Both regions together are referred 
to as the C1 domain. Each of the cysl and cys2 domains 
binds two zinc ions (Ahmed et al., 1991; Hubbard et al., 
1991). The solution structure of the cys2 domain of PKCa 
determined in the absence of activators (Hommel et al., 
1994) shows that the domain contains two small 13 sheets 
and that the two zinc-binding sites are formed by noncon- 
tiguous sections of primary sequence. Although these do- 
mains are sometimes referred to as zinc fingers, they are 
structurally unrelated to any of the nucleic acid-binding 
zinc finger proteins. Recombinant PKC cysl and cys2 do- 
mains bind to phorbol esters and DAG with essentially the 
same high affinities as do intact PKCs (Ono et al., 1989; 
Burns and Bell, 1991 ; Quest et al., 1994; Kazanietz et al., 
1994). These domains also bind several other classes of 
pharmacologically active natural products, including the 
potent PKC-directed anticancer agent bryostatin-1 (Pettit, 
1991). 
Despite intense interest in the structure and mechanism 
of PKC, intact PKCs have so far resisted experimental 
structure determination. The phorbol ester-activated form 
of PKC is particularly recalcitrant because it becomes 
tightly associated with the membrane fraction and is highly 
flexible as judged by proteolytic susceptibility (Burns and 
Bell, 1991; Lester, 1992; Newton, 1993). Both of these 
factors are highly unfavorable for structural studies. As 
part of an alternative "piecemeal" approach to understand- 
ing the active form of PKC, we have determined the crystal 
structure of a single cysteine-rich activator-binding do- 
main both alone and in complex with the agonist phorbol 
13-acetate. The complex structure has been refined to an 
R factor of 19.4% at 2.2 ,~, resolution, which allows an 
accurate analysis of the intricate hydrogen-bonding net- 
work in the activator-binding site. 
Results and Discussion 
Structure and Conformation of the Cys2 Domain 
The cys2 domain of PKC8 (Figure 1) consists of two small 
sheets and a short C-terminal a helix. Phorbol binds 
between residues 239-242 and 251-254 (Figures 1-2), 
which are in or near the 13 conformation and comprise most 
of 132 and 1~3. Except for one hydrogen bond between 242 
and 251, these sections do not form direct 13 sheet hydro- 
gen bonds. The four rings O f phorbol are inserted length- 
wise into a narrow groove between the two segments, with 
the C20 alcohol buried in the bottom. The bottom of the 
groove is formed by the side chains of Tyr-238, Leu-251, 
and Gin-257. The walls are formed by the main chain from 
239-242 and 250-254 and the side chains of Met-239, 
Pro-241, Thr-242, Leu-250, and Leu-254. 
In the absence of phorbol binding, the gap between the 
strands contains bound water molecules that form bridg- 
ing hydrogen bonds like those at the ends of 13 sheets in 
other proteins (Finer-Moore et al., 1992). Bound phorbol 




Figure 1. Stereoview of Phorbol Ester Binding 
to the Cys2 Domain 
Stereoview drawn with Molscript (Kraulis, 
1991). 
oxygens replace the lost bridging hydrogen bonds. The 
PKC activator-binding site is thus constructed by pulling 
apart two 13 strands to generate unpaired hydrogen- 
bonding partners for the ligand. To our knowledge, the 
"unzipped" 13 sheet of the PKC activator-binding domains 
provides an unprecedented architecture for a small mole- 
cule-binding site. 
The overall protein fold in the crystal structure is in rea- 
sonably close agreement with the solution structure (Horn- 
reel et al., 1994). The main-chain backbone differs by 1.8 
/~. rms for all residues. The largest differences, up to 7 ,~, 
are concentrated near 132 and 133 and at the C-terminus, 
which are not well defined in the solution structure. The 
well-defined structure of the two phorbol-binding seg- 
ments of 132 and 133 in the crystal structure is in contrast 
with the lack of definition of these regions in the solution 
structure (Hommel t al., 1994). These segments are well 
ordered (<B> = 15 ,~2) in the crystal both in the presence 
and absence of phorbol. In solution, residues of the cys2 
domain of PKC~ corresponding to 239-240 and 254-257 
of PKC8 are not well defined by experiment. The absence 
of bound phorbol in the solution structure cannot account 
for the apparent difference, because the crystal structure 
is equally rigid regardless of phorbol binding. 
The apparent discrepancy could be explained if these 
regions were highly mobile in solution but not in the crystal, 
or if there were simply not enough nuclear Overhauser 
effect (NOE) constraints to define these regions. Crystal 
contacts bury 45% of the total solvent-accessible surface 
area (Lee and Richards, 1971) of the protein; 59% of this 
buried surface area involves hydrophobic interactions. 
Tyr-238, Met-239, Phe-243, and Trp-252, which are adja- 
cent in sequence to the phorbol-binding residues, are al- 
most entirely buried in hydrophobic crystal contacts. 
These extensive hydrophobic ontacts might be responsi- 
ble for anchoring and rigidifying the phorbol-binding seg- 
ments relative to the solution state. If this is the case, it 
is intriguing that the conformation stabilized by the crystal 
contacts is one capable of binding phorbol. Alternatively, 
132 and 133 might be rigid even in solution. Most of the 
phorbol-binding segments of 132 and 133 are about 3/~ far- 
ther apart than if they had been in a conventional 13 sheet. 
Furthermore, most of the side chains in these regions have 
few interactions with the rest of the protein. Water- 
mediated, rather than direct, interactions play a major role 
in stabilizing the local structure in the unliganded state. 
Under these conditions, it would not be surprising if rela- 
tively few NOEs were to exist. 
Structural Determinants for Phorbol Ester Binding 
Five hydrogen bonds are formed between three of the 
phorbol oxygens and the protein (Figure 3). The C3 oxygen 
accepts a hydrogen bond from the main-chain amide of 
Gly-253. The C4 hydroxyl donates a hydrogen bond to the 
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Figure 2. Stereoview of the Phorbol Ester- 
Binding Site 
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Figure 3. Hydrogen Bond Networks at the Phorbol Ester-Binding Site 
(A) Schematic of hydrogen-bonding interactions inthe phorbol-binding 
site. 
(B) Schematic of the role of the consensus Gin-257 at the junction 
between the large ~ sheet and the pulled-apart portion of the small 
sheet. Secondary structure lements are identified for residues hown. 
Gly-253 immediately follows the end of 63. 
main-chain carbonyl of Gly-253. The C20 hydroxyl accepts 
a hydrogen bond from the main-chain amide of Thr-242 
and donates a bifurcated hydrogen bond to the main-chain 
carbonyls of Thr-242 and Leu-251, acting as an interstrand 
bridge. The C12 hydroxyl faces outward from the binding 
site. Neither the C9 hydroxyl nor the 13-acetyl hydrogen 
bond with the protein, but form an intramolecular hydrogen 
bond instead. Since both of the normal positions of esterifi- 
cation point away from the protein, the tails of long-chain 
phorbol esters probably do not interact directly with the 
protein. The three-, five-, and seven-membered phorbol 
rings and the 13-acetyl group have numerous van der 
Waals interactions with both the polar bottom and the hy- 
drophobic sides of the groove. The six-membered ring has 
no interactions except for a single contact between the 
bottom of the ring and the main chain at Met-239. This 
latter portion of the phorbol is relatively mobile. B factors 
for this portion of the phorbol are in the 30-41 ,&,2 range 
compared with 16 ,&,2 for the most tightly bound phorbol 
atom, 020. 
Binding leads to a 0.4 ,~ opening of the groove as mea- 
sured between the main chain of Pro-241 and Gly-253. 
This shift is only marginally greater than the estimated 
coordinate error, but appears to be required to prevent a 
PKC a lpha  1 
PKC a lpha  2 
PKC beta  1 
PKC beta  2 
PKC galena 1 
PKC garmma 2 
PKC de l ta  1 
PKC de l ta  2 
PKC eps 1 
PKC eps 
PKC eta 
PKC eta 2 
PKC theta  1 
PKC theta  2 








pl p2 ~3 
cO o Lo mo 
Figure 4. Alignment of PKC Cysteine-Rich Domains 
Proteins in the upper group bind phorbol esters and those in the lower 
group do not. Identically conserved residues are enclosed in stippled 
boxes. Conserved but nonidentical residues implicated by the struc- 
ture in binding or structural integrity of the domain are shown in open 
boxes. Secondary structure lements and PKC5 cys2 numbering are 
shown below the sequences. The sequence of PKC~ is from bovine; 
PKC~, PKCT, PKC& and PKC~ are from rat; PKCTI, PKC0, PKC~, and 
Vav are from murine; n-chimaerin and c-Raf are from human; and 
unc-13 is from C. elegans. Domains of PKCs containing both cysl 
and cys2 are labeled (1) and (2). PKC homologs whose phorbol ester- 
binding properties are unknown are not shown. Details of the alignment 
are described by Kazanietz et al. (1994). 
steric conflict between the C4 oxygen and the main-chain 
carbonyl at Gly-253. The 0.3 h, rms overall main-chain 
atomic coordinate difference between the entire unli- 
ganded and phorbol-bound structures is probably insig- 
nificant. 
Structure-activity relationships of phorbol esters and 
other PKC activators have been under intense study for 
more than 20 years (Hecker, 1978; Rando and Kishi, 
1992). The complex structure explains much of the ob- 
served structure-activity data. 4-deoxy phorbol esters, 
which are active but have diminished affinity (Hecker, 
1978), cannot form a hydrogen bond with the main-chain 
carbonyl at Gly-253. Methylation of the C4 oxygen would 
destroy its ability to donate a hydrogen bond to the Gly-253 
carbonyl and create a severe steric conflict, explaining the 
inactivity of 4-O-methyl phorbol esters (Hecker, 1978). The 
lack of interactions involving the C12 hydroxyl explains 
the high affinity of 12-deoxyphorbol esters (Hecker, 1978). 
The 09 hydroxyl and acetyl carbonyl may be important 
because removal of either one of these polar moieties sep- 
arately would leave the other with an unsatisfied hydrogen 
bond in the lipid phase. Phorbol esters and DAG bind com- 
petitively through interactions that have long been be- 
lieved to be stereochemically equivalent (Rando and Kishi, 
1992). The tightly packed surroundings of the C20 hy- 
droxyl and its role in both donating and accepting hydro- 
gen bonds are consistent with the model-based prediction 
(Rando and Kishi, 1992) that this position is analogous to 
the 3-hydroxyl of DAG. Local packing is consistent with 
differences in activity between diastereomers of 3-methyl 
DAG (Rando and Kishi, 1992). 
Implications for PKC Homology Domains of raf 
and ray Proto-Oncogenes 
One copy of the PKC cysteine-rich domain is present in 
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Figure 5. Molecular Surface Properties of the Cys2 Domain 
(A) Molecular surface of the cys2 domain colored by residue type (A. 
Nicholls, GRASP, Columbia University). Phorbol binds in the deep 
groove at the top of the structure, shown with carbons colored yellow 
and oxygens colored red. On the protein surface, hydrophobic resi- 
dues are green, positively charged residues ar  blue, negatively 
charged residues are red, and neutral polar residues are white. 
(B) Model for the membrane-inserted form of the cys2-phorbol ester 
complex based on the molecular surface of the protein-phorbol com- 
plex and the crystal structure of dimyristoyl phosphorylcholine 
(Pascher and Pearson, 1979; Hauser et al., 1981). The molecular sur- 
face of the protein-phorbol complex is colored as above, except that 
phorbol is also colored green. The membrane model is intended only 
to represent the estimated depth of penetration of the protein into the 
bilayer. Lipids in front and in back of the domain have been removed for 
clarity, and no effort has been made to model the membrane structure 
immediately below the domain. 
several other signaling proteins, including the nonphorbol 
ester-binding proto-oncogene proteins Vav and c-Raf 
(Figure 4). Vav, c-Raf, and the nonphorbol ester-binding 
isozyme PKC~, all diverge from the phorbol ester-binding 
PKC consensus sequence at the position corresponding 
to Pro-241 (Kazanietz et al., 1994). The nonphorbol ester- 
binding proteins differ at other positions, but have no other 
common points of divergence. The restriction of the 
angle of Pro to -60 ° prevents an antiparallel arrangement 
of the adjoining peptide planes, helping to prevent resi- 
dues 240-242 from "zipping-up" with 251-253 into a 13 
sheet. 
The complex shows how two other PKC consensus resi- 
dues help form the phorbol-binding site. Gly-253 is a key 
phorbol ligand and occupies angles (¢, ~) that are disal- 
lowed for other residues. The Gin-257 side chain does not 
interact with phorbol, but forms bridging hydrogen bonds 
where the large 13 sheet comes apart at one end of the 
binding groove (Figure 3). The absolute conservation of 
the consensus Pro and Gin suggests that destabilization 
of hydrogen bonding between the two separated strands 
is critical for activator binding. 
Restoring the consensus sequence to PKCr~ by muta- 
genesis fails to confer phorbol binding (Kazanietz et al., 
1994); hence, nonidentical residues are also required. Ser- 
240 is predicted to be within the membrane. This position 
is neutral in phorbol-binding proteins, but charged in some 
of the nonphorbol-binding proteins. In phorbol-binding pro- 
teins, the position corresponding to Ser-240 can be either 
Ser, Gin, Gly, or Val, making it the most variable binding 
site residue and suggesting a role in isozymic differences 
in activator specificity. Phe-243, Leu-250, Trp-252, and 
Leu-254 are all exposed and positioned to point into the 
membrane. These four positions are hydrophobic in all 
phorbol-binding proteins, but sometimes polar in nonphor- 
bol-binding proteins. Tyr-238 and Leu-251 are mostly bur- 
ied and form part of the floor of the binding roove; they 
correspond to hydrophobic residues in all sequences. 
Structural Basis for Phorbol Ester-Promoted 
Membrane Insertion 
The structure shows how membrane insertion (Lester, 
1992) by PKCs might occur. The "top" third of the surface 
(Figu re 5) is composed almost entirely of hydrophobic resi- 
dues and is completely devoid of charged groups. Soluble 
proteins almost never contain a contiguous hyclrophobic 
region covering such a large proportion of the entire sur- 
face. The =middle" third is overwhelmingly composed of 
positively charged side chains. The chain termini are close 
together at the "bottom" of the domain, suggesting connec- 
tions to soluble domains will be well above the membrane. 
The layered surface suggests the cys2 domain could bury 
itself top down 6-8 A into the bilayer (Figure 5). Similar 
mechanisms for membrane insertion are thought o occur 
for defensins (Hill et al., 1991) and prostaglandin H2 syn- 
thase (Picot et al., 1994). Some of the basic side chains 
from the middle of the domain are positioned to interact 
with acidic phospholipid headgroups. 
PKC activator domain partitioning into the membrane 
is strongly favored by the presence of phorbol or DAG 
PKC Cys2 Domain-Phorbol Ester Complex 
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Table 1. Data Reduction and Phasing Statistics as a Function of Resolution 
Data Reduction 
din,, (A.) All 3.76 2.98 2.61 2.37 2.20 ' 2.07 1.95 
Rmerge (MAD ~2) 0.072 0.061 0.069 0.082 0.095 0.106 
Rmerge (lab) 0.061 0.045 0.065 0.089 0.105 0.113 0.110 0.098 
Rme,g, (phorbol) 0.067 0.046 0.068 0.101 0.138 0.161 
Complete (MAD) 79.6 76.6 80.5 79.8 81.6 80.2 
Complete (lab) 88.8 100.0 100.0 100.0 96.3 82.3 67.4 44.0 
Complete (phorbol) 94.6 99.3 98.9 98.2 96.7 79.4 
Refinement 
Ror~,t (unbound) 0.197 0.165 0.180 0.205 0.216 0.237 0.231 0.262 
Ro~st (phorbol) 0.194 0.159 0.186 0.214 0.236 0.252 
MAD Phasing 
d~,~n (/~) All 9.4 6.2 4.9 4.2 3.7 3.4 3.1 
N 1242 68 91 136 151 176 189 220 
Rcu,~s 0.48 0.37 0.33 0.38 0.59 0.53 0.66 0.58 
FH/Er~s (iso) 1.72 1.63 1.84 1.93 1.72 1.57 1.36 1.90 
FH/Err, s (ano) 1.87 0.94 1.02 1.00 2.53 3.11 3.20 1.56 







araerge = ~lJi- <1> liT_. <1>, with Bijvoet pairs treated as equivalent. Rme,ge values for MAD data sets were very similar for all three wavelengths and 
are shown for the wavelength at which they were largest. "Complete" is the percentage of possible reflections measured with 1/o(I) 1> 0 (1/o(I) I> 
1 for MAD data); Rcr~,t = :~JFo - FcJ/ZFo for all amplitudes (no F/a(F) cut-off applied) measured in the indicated resolution bin; N is the number of 
reflections for which MAD phases were calculated; Rc,,,,, = T_,JJFpH _+. Fp J - FHI/ZJFpH --+ Fp] for the mock isomorphous differences of centric 
reflections due to dispersive differences; <FH>/E,r,, (iso) and (ano) indicate dispersive and anomalous phasing power for acentric reflections. For 
data reduction and phasing statistics, "All" refers to all data to the highest resolution used. For F~r~t, =All" refers to data from 6.0/~ to the highest 
resolution used. Columns show statistics for bins of data with the upper resolution limit indicated. The lower resolution limit for each bin is that 
of the preceding bin; for the leftmost bin, it is the same as the overall imit. 
(Burns and Bell, 1991; Lester, 1992; Newton, 1993). This 
behavior can be explained by the structure of the activator- 
binding site and by the nature of the protein surface. Mem- 
brane insertion of the unl iganded activator-binding site 
would have to lead to either a loss of hydration between 
the unzipped strands or to the insertion of bound water 
molecules into the membrane along with the protein. Ei- 
ther of these situations involve several unsatisfied hydro- 
gen bonds at the prote in-membrane interface, which is 
highly unfavorable. By contrast, phorbol binding satisfies 
the hydrogen bonding potential of the activator-binding 
groove. The activator forms a hydrophobic cap over the 
exposed polar main-chain groups. When an activator is 
bound, the domain can fully bury its hydrophobic exterior 
surface in the membrane without suffering an unfavorable 
loss of hydrogen bonds in the groove. 
Water-soluble short-chain phorbol esters such as phor- 
bol 13-acetate can function as PKC activators, but with 
potency reduced by several orders of magnitude (M. G. K. 
and P. M. B., unpublished data). Only the water-insoluble 
long-chain phorbol esters are potent PKC activators. Be- 
cause these compounds are completely partit ioned into 
the membrane,  protein-phorbol  binding is directly l inked 
to membrane association by the protein. In combination, 
these factors can reasonably account for the coupling of 
ligand binding to membrane insertion. 
The Role of Phorbol Ester Binding 
in PKC Activation 
The structure of the activator-binding domain-phorbol  es- 
ter complex helps clarify the role of phorbol esters in PKC 
activation. Phorbol ester binding does not produce a signif- 
icant conformational change within the activator-binding 
domain. Rather, it acts to cover the polar interior of the 
groove and completes a contiguous hydrophobic surface 
over a large portion of the domain. The long-chain lipid 
tails of PKC activators are probably not directly involved 
in binding to PKC, but instead retain the activator within 
the membrane. The retention of the long-chain phorbol 
esters in the membrane means that the favorable free 
energy of protein-phorbol  binding can be used to drive 
the insertion of the protein into the membrane.  The present 
structural results suggest that phorbol esters activate PKC 
by altering the nature of the protein surface and by stabiliz- 
ing the membrane-inserted state, rather than by inducing 
a conformational change at the activator-binding site. 
Experimental Procedures 
Protein Expression and Purification 
DNA coding for residues 231-280 of mouse PKC8 (Mischak et al., 
1991) was subcloned into the BamHI and EcoRI sites of pGEX-2T 
(Pharmacia) and expressed as a thrombin-cleavable glutathione 
S-transferase fusion protein in Escherichia coli XL1-Blue. Phorbol es- 
ter binding was confirmed as described (Kazanietz et al., 1994). The 
vector construction led to a postcleavage xpressed protein containing 
N- and C-terminal extensions with the sequences Gly-Ser-Arg-Arg-Ala- 
Ser-VaI-Gly-Ser and Glu-Phe-Ile-VaI-Thr-Asp, respectively; hence, the 
entire protein contains 65 amino acid residues. Cells were grown in 
an 8 liter fermenter (BioFIo IV, New Brunswick Scientific) to an optical 
density at 600 nm of 10.0, induced with 0.3 mM IPTG, and harvested 
6 hr after induction. Cells were lysed in 1 liter of phosphate-buffered 
saline (PBS), 1 mg/ml lysozyme, 1% Triton X-100, 1 p.g/ml eupep- 
tin, 1 mM PMSF. The suspension was sonicated and centrifuged at 
30,000 x g for 30 min. Glutathione-Sepharose 4Bbeads (20 ml) (Phar- 
macia) were added to the supernatant. The resin was equilibrated and 





Figure 6. Electron Density at the Phorbol Ester-Binding Site 
(A) Refined structure of the cys2 domain superimposed on 2.8/~. solvent-flattened MAD density (1 .O a). 
(B) Phorbol complex superimposed on 2.2 A [2Fo - Fc](lc=~ density (0.6 a). The appearance of the map is similar if contoured at 1.0 a, except that 
the off-ring methyl of the six-memberad ring, which has a high B factor and no interactions with the protein, is out of density. 
from the resin was carried out with 20 U of thrombin (Boehr!nger- 
Mannheim) in 20 ml of PBS for 16 hr at 4°C. The cleaved protein was 
collected from the supernatant and centrifuged for30 min at 30,000 x 
g. The supernatant was loaded (10 ml at a time) on a 2.6 x 60 cm 
Superdex S-200 gel filtration column (Pharmacia) equilibrated in 0.5 M 
NaCI, 0.1 M triethanolamine HCI (pH 7.0) and run at 1 ml/min. Peak 
fractions were pooled, adjusted to 100/0 glycerol, 1 mM PMSF, 1 mM 
DTT, and stored at -80°C. 
Protein Crystallization 
Protein was concentrated to 8 mg/ml by precipitation with 55% ammo- 
nium sulfate and resuspension in 0.1 M phosphate buffer (pH 6,8), 1 
mM DTT. Microcrystalswere obtained by hanging dropvapor diffusion, 
using a sparse matrix screen (Hampton Research) to obtain initial 
conditions. Protein (6 ~d) was mixed with an equal volume of well 
solution containing 25% isopropanol, 0,2 M ammonium acetate, 0.1 
M sodium phosphate (pH 6.8) and incubated at 4°C. Using the micro- 
PKC Cys2 Domain-Phorbol Ester Complex 
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Table 2. MAD Parameters 
<AF'>/<F> 
Z~ Z2 <AF">/<F> f' f" 
X~ --  -- 0.031 -9.19 2.04 
Z2 0.050 - -  0.051 -7.11 4.26 
Z3 0.085 0.069 0.049 -3.53 3.79 
AF' and AF" are the measured dispersive and anomalous amplitude 
differences, f' and f" are in electrons, and the wavelengths used are 
Z~ = 1.2826, ~.2 = 1.2818, and Z3 = 1.2616 ,~. 
crystals as seeds, plates of approximately 0.4 mmx 0.4 mm x 0.01 
mm were obtained. Cocrystallization with phorbol 13-acetate was car- 
ried out as above, except with the addition of I mM phorbo113-acetate 
(LC Laboratories) and 5% methanol, and yielded crystals no larger 
than 0.3 mm x 0.3 mm x 0.01 mm. 
Crystallographic Data Collection 
Data were collected from frozen crystals using graphite-mono- 
chromated Cu K~ radiation from a Rigaku RU-200 rotating anode 
source operating at 5 kW and an RAXIS II imaging plate detector 
system (Table 1). Crystals were equilibrated in 15% sucrose, 25% 
PEG 4000, 0.1 M sodium phosphate buffer (pH 7.2) and mounted in 
rayon loops prior to flash freezing in a dry nitrogen stream at -180°C. 
Data were collected in 2 ° exposures for 40 rain per exposure. The 
space group and cell dimensions are C222~ and a = 32.4 ~,, b = 
63.5 ,~, c = 65.5 ,~, (Table 1), based on autoindexing with DENZO (Z. 
Otwinowski, Department of Molecular Biophysics and Biochemistry, 
Yale University) and manual inspection of systematic absences. Multi- 
wavelength anomalous dispersion (MAD) data were collected from 
frozen crystals at the X4A beamline, National Synchrotron Light 
Source, Brookhaven National Laboratory, at three wavelengths (Table 
2). Bijvoet pairs were collected using inverse beam geometry. Image 
plates were exposed for 4 ° oscillations with a 1° overlap, for 60-90 
s each, and scanned on a Fuji BAS 2000 scanner. Data integration 
and reduction were carried out with DENZO, and only fully measured 
reflections were retained. 
MAD Structure Determination and Refinement 
Bijvoet and wavelength scaling was carried out by local scaling using 
an unpublished program written by J. H. H. Anomalous scattering 
factors for native zinc ions (Table 2) were obtained from a fluorescence 
scan of the crystal (Hendrickson et al., 1988). Native zinc structure 
factors were estimated (Terwilliger, 1994a) and used to locate the zinc 
ions in a Patterson synthesis. Dispersive and anomalous differences 
were cast into isomorphous replacement formalism and refined with 
HEAVY (Terwilliger, 1994b) using the origin-removed Patterson 
method (Table 1). The resulting 2.8 h. resolution map was subjected 
to solvent flattening (Wang, 1985) in reciprocal space (W. Furey, 
PHASES, University of of Pittsburgh) with a solvent fraction of 0.45 
(Figure 6). Map interpretation with CHAIN (Sack, 1988) was initiated 
at the zinc sites and facilitated by the availability of the solution struc- 
ture of the homologous cys2 domain of PKCa. The structure was re- 
fined with XPLOR (Brenger et al., 1987) by slow cooling from 6000 K 
to 300 K, followed by conjugate gradients minimization and restrained 
temperature factor refinement versus all measured amplitudes (no 
F/a(F) cutoff was appliedand no "test set" was excluded from refine- 
ment) from 6.0 to 1.95 A data (Table 3). The refined model o1 the 
unliganded domain includes the entire activator-binding domain and 
all of the vector-derived sequences except for the first residue in the 
N-terminal extension and the last residue in the C-terminal extension 
(Table 3). The overall R factor is 0.197 for all data in the resolution 
range 6.0 to 1.95/~ (Table 3). 
Phorbo113-acetat e was located using [Fob,(phorbol) - Fob~(native)]aMAD, 
[Fo~(phorbol) - FoD,(native)]~c=~, and [Fob,(phorbol) - Fc=o(omit)]Qo=c dif- 
ference syntheses. All maps used in refinement were calculated with 
all low r~solution data included, using four-parameter scaling carried 
out with TNT (Tron rudet al., 1987) to account for the scattering contri- 
bution of bulk solvent. The structure of the phorbol complex was re- 
fined as above, except using all measured amplitudes from 6.0 to 2.2 
Table 3. Parameters of the Refined Models 
Parameter Free Complex 
dmi, (,~,) 1.95 2.20 
N (6.0-din,,) 4073 3215 
R (6.0-dr,,n) 0.197 0.194 
R (40.0-dins,) 0.224 0.212 
Rms &bond (.~) 0.014 0.014 
Rms Aangle (degrees) 2.9 3.2 
Rms AB (bonds) 3.3 3.2 
Number of protein atoms 510 489 
Protein <B> (~2) 16.3 19.4 
Protein Bin=, (A 2) 2.0 2.0 
Protein Bm,~ (,~2) 58.6 59.0 
Number of phorbol atoms 0 29 
Phorbol <B> (~2) -- 34.3 
Phorbol Bm,n (A 2) - 16.0 
Phorbol Bm~ (A 2) - 41.0 
Number of water molecules 59 39 
Water <B> (~2) 31.5 29.9 
Water Bin,, (A 2) 4.5 7.0 
Water Br,~ (A 2) 49.0 48.0 
N is the number of reflections used in refinement, R is the crystallo- 
graphic R factor defined in Table 1, and B refers to refined atomic 
thermal parameters. All quantities are obtained from XPLOR (BrSnger 
et al., 1987) except the R factor from 40.0 ,~ to drain that was obtained 
using TNT (Tronrud et al., 1987) with four-paremeter scaling and the 
correlated B factor deviations of bonded atoms that were calculated 
with the BCORREL module of TNT (Tronrud et al., 1987). 
,~. (Table 3). Side chains of Arg-273, Glu-274, and the first vector- 
derived Arg were omitted from the complex model because of their 
high mobility. There are no nonglycine ($, ~) pairs in the disallowed 
region of the Ramachandran plot of either model, and all stereocherni- 
cal parameters are as good or better than expected for the resolution 
of the refinements (Laskowski et al., 1993). The overall R factor for 
the phorbol complex model is 0.194 for all data from 6.0 to 2.20 .~. 
(Tables 1 and 3). Coordinates will be deposited with the Protein Data 
Bank at Brookhaven and can be obtained prior to release by sending 
e-mail to HURLEY@TOVE.NIDDK.NIH.GOV. 
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